Skip to content

Impact of "active" vs. "passive" interferers on the quality of a simulated resuscitation

Impact of "active" vs. "passive" interferers on the quality of a simulated resuscitation - ASPIRATION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024761
Enrollment
1229
Registered
2021-03-10
Start date
2017-11-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

simulated cardiac arrest I46

Interventions

Group 1: Control group: Simulated resuscitation WITHOUT "interferer". Group 2: Intervention group: Simulated resuscitation WITH "interferers".

Sponsors

Arbeitsgemeinschaft Intensivmedizin (AIM) Arnsberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participant course emergency medicine; participant course intensive care medicine; licensed physician

Exclusion criteria

Exclusion criteria: No informed consent; pregnancy

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the percentage of hands-on time, defined as time of actual chest compressions divided by the total time interval of the study period. A power analysis, based on data of pilot experiments, revealed that approximately 50 teams have to be studied in each study arm to detect a between-group difference of 10% in the primary outcome with significance levels of 0.05 and 80% power. Accordingly, we terminated the study as soon as at least 50 videotapes of sufficient quality for each study arm were available. For organizational reasons, the number of available videotapes of sufficient quality can be assessed only after completion of each educational course.

Secondary

MeasureTime frame
Secondary outcomes include the number and time of interactions with the interferer, adherence to various aspects of the international CPR guidelines, and the NASA task load data. The effect of designated leadership is assessed as secondary outcome for all outcomes analyzed.

Countries

Germany

Contacts

Public ContactAndrea Oendorf

Gertrudes Hospital

andrea.oendorf@rub.de+49-(0)209 61910

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026